Synthesis and inhibition study on tripeptide inhibitor modified poly(l-lysine) dendrimers

Journal of Biomaterials Applications

Volumn 27, Issue 1, 2012, Pages 17-26

  Zhang, Xiaowei ^a   Luo, Kui ^a   Wang, Gang ^a   Nie, Yu ^a   He, Bin ^a   Wu, Yao ^a   Gu, Zhongwei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

cytotoxicity; Poly(l lysine) dendrimer; proteasome tripeptide inhibitor

Indexed keywords

BIOLOGICAL BARRIER; DENDRITIC STRUCTURES; FLUORIMETRIC; GENE DELIVERY; GENE TRANSFECTION; GENE VECTORS; INHIBITOR CONCENTRATION; L-LYSINE; LIQUID-PHASE METHOD; NONVIRAL; NONVIRAL VECTORS; PEPTIDE DENDRIMERS; PEPTIDE INHIBITORS; PROTEASOME INHIBITORS; PROTEASOMES; TRIPEPTIDE; VINYL ESTERS;

AMINO ACIDS; CYTOTOXICITY; DEGRADATION; GENE TRANSFER; GENES; PEPTIDES;

DENDRIMERS;

DENDRIMER; ENZYME INHIBITOR; OLIGOPEPTIDE; POLYLYSINE; PROTEASOME;

ANIMAL; ARTICLE; CELL STRAIN 3T3; CHEMISTRY; DRUG ANTAGONISM; DRUG SCREENING; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; MASS SPECTROMETRY; MOUSE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DENDRIMERS; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; NIH 3T3 CELLS; OLIGOPEPTIDES; POLYLYSINE; PROTEASOME ENDOPEPTIDASE COMPLEX; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84863651303     PISSN: 08853282     EISSN: 15308022     Source Type: Journal    
DOI: 10.1177/0885328210386821     Document Type: Article

References (26)

1. Newkome GR, Moorefield CN, Vögtle F Dendritic molecules: concepts, synthesis and perspectives. Weinheim: VCH ; 1996:
2. Klajnert B, Bryszewska M. Dendrimers: properties and applications. Acta Biochim Pol. 2001 ; 48: 199-208
3. Sadler K, Tam JP. Peptide dendrimers: applications and synthesis. Rev Mol Biotechnol. 2002 ; 90: 195-229
4. Crespo L, Sanclimens G, Pons M, et al. Peptide and amide bond-containing dendrimers. Chem Rev. 2005 ; 105: 1663-1682
5. Scholl M, Kadlecova Z, Klok HA. Dendritic and hyperbranched polyamids. Prog Polym Sci. 2009 ; 34: 24-61
6. Schatzlein AG. Non-viral vectors in cancer gene therapy: principles and progress. Anti-Cancer Drugs. 2001 ; 12: 275-304
7. Dufès C, Uchegbu IF, Schätzlein AG. Dendrimers in gene delivery. Adv Drug Delivery Rev. 2005 ; 57: 2177-2202
8. Mintzer MA, Simanek EE. Non-viral vectors for gene delivery. Chem Rev. 2009 ; 109: 259-302
9. Dutta T, Jian NK, McMillan NAJ, et al. Dendrimer nanocarriers as versatile vectors in gene delivery. Nanomed Nanotechnol Biol Med. 2010 ; 6: 25-34
10. Liu D, Knapp JE. Hydrodynamics-based gene delivery. Curr Opin Mol Ther. 2001 ; 3: 192-197
11. Wiethoff CM, Middaugh CR. Barriers to nonviral gene delivery. J Pharm Sci. 2003 ; 92: 203-217
12. Kim J, Chen CP, Rice KG. The proteasome metabolizes peptide-mediated nonviral gene delivery systems. Gene Ther. 2005 ; 12: 1581-1590
13. Duan DS, Yue YP, Yan ZY, et al. Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. J Clin Invest. 2000 ; 105: 1573-1587
14. Marastoni M, Baldisserotto A, Cellini S, et al. Peptidyl vinyl ester derivatives: new class of selective inhibitors of proteasome trypsin-like activity. J Med Chem. 2005 ; 48: 5038-5042
15. Marastoni M, Baldisserotto A, Trapella C, et al. P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors. Bioorg Med Chem Lett. 2006 ; 16: 3125-3130
16. Martin ME, Rice KG. A novel class of intrinsic proteasome inhibitory gene transfer peptides. Bioconjugate Chem. 2008 ; 19: 370-376
17. Ohsaki M, Okuda T, Wada A, et al. In vitro gene transfection using dendritic poly(l-lysine). Bioconjugate Chem. 2002 ; 13: 510-517
18. Eom KD, Park SM, Tran HD, et al. Dendritic α,ε-poly(l-lysine)s as delivery agents for antisense oligonucleotides. Pharm Res. 2007 ; 24: 1581-1589
19. Fehrentz JA, Castro B. An efficient synthesis of optically active α-(t-butyoxycarbonylamino)-aldehydes from α-amino acids. Synthesis. 1983 ; 8: 676-678
20. Hover JA, Bock CW, Bhat KL. Synthesis of chiral 3,4-disubstituted pyrroles from l-amino acids. Heterocycles. 2003 ; 60: 791-798
21. Davies CE, Heightman TD, Hermitage SA, et al. Convenient preparations of racemic and enantiopure methyl 6-oxopipecolate. Synth Commun. 1996 ; 26: 687-696
22. Schmidtke G, Kraft R, Kostka S, et al. Analysis of mammalian 20S proteasome biogenesis: the maturation of β-subunits is an ordered two-step mechanism involving autocatalysis. EMBO J. 1996 ; 15: 6887-6898
23. Beyette J, Mason GG, Murray RZ, et al. Proteasome activities decrease during dexamethasone-induced apoptosis of thymocytes. J Biochem. 1998 ; 332: 315-320
24. Myung J, Kim KB, Crews CM. The ubiquitin-proteasome pathway and proteasome inhibitors. Med Res Rev. 2001 ; 21: 245-273
25. Adams J, Kauffman M. Development of the proteasome inhibitor velcadeTM (bortezomib). Cancer Invest. 2005 ; 22: 304-311
26. Bogyo M, Wang EW. Proteasome inhibitors: complex tools for a complex enzyme. Curr Top Microbiol Immunol. 2002 ; 268: 185-208